The severity of SCD complications differ depending on variations in hemoglobin haplotype, HbF, α-thalassemia, Glucose-6-phosphate dehydrogenase deficiency, and UGT1A1 promoter polymorphisms [26]. The gene discussed is UGT1A1; the disease is thalassemia.